2008年，日本第三大医药公司DaiichiSankyo购买了印度的仿制药品生产商Ranbaxy，一定程度上使药品国产化。
In 2008 Daiichi Sankyo, Japan's third-biggest drug company, bought Ranbaxy, an Indian generics-maker, in part to bring the drugs home.
替伐普坦制造商，日本大冢制药有限公司负责本研究费用，Konstam是该研究顾问之一。
Tolvaptan's maker, Otsuka Pharmaceutical Co. of Japan, paid for the study and Konstam is one of its consultants.
替伐普坦制造商，日本大冢制药有限公司负责本研究费用，Konstam是该研究顾问之一。
Tolvaptan's maker, Otsuka Pharmaceutical Co. of Japan, paid for the study and Konstam is one of its consultants.
应用推荐